Patients with chronic hepatitis B (CHB) undergoing interferon (IFN)-α-based therapies often
exhibit a poor HBeAg serological response. Thus, there is an unmet need for new therapies …

Lysine lactylation (Kla) is a recently discovered histone mark derived from metabolic lactate.
The NAD + ‐dependent deacetylase SIRT3, which can also catalyze removal of the lactyl …

Relapse is a leading cause of death after allogeneic hematopoietic stem cell transplantation
(allo-HSCT) for acute myeloid leukemia (AML). However, the underlying mechanisms …

Background Natural killer (NK) cells are innate lymphoid cells that mediate antitumour and
antiviral responses. However, very little is known about how ageing influences human NK …

Background Patients undergoing surgical resection of hepatocellular carcinoma (HCC) are
at risk of recurrence; however, the underlying mechanism remains poorly understood. …

Haematologic malignancies account for a large proportion of cancers worldwide. The high
occurrence and mortality of haematologic malignancies create a heavy social burden. …

Heterogeneous networks (HetNets) are expected to be one of the major performance
enhancement enablers of LTE-Advanced. Due to significantly challenging interference scenarios, …

Cell membrane chromatography (CMC) is an ideal method for screening potential active
components acting on target cell membranes from a complex system, such as herbal medicines…

Hepatitis B virus (HBV) is a hepatotropic virus with the potential to cause chronic infection,
and it is one of the common causes of liver disease worldwide. Chronic HBV infection leads to …

Pico cell has been brought to cellular networks as a new technology to deliver cost-effective
coverage and capacity to hard-to-reach places, and also increase capacity by cell splitting in …